Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers

Psychopharmacology (Berl). 2018 Feb;235(2):491-503. doi: 10.1007/s00213-017-4807-2. Epub 2018 Jan 5.

Abstract

Rationale: Disruption of auditory event-related evoked potentials (ERPs) P300 and mismatch negativity (MMN), electrophysiological markers of attentive and pre-attentive cognitive processing, is repeatedly described in psychosis and schizophrenia. Similar findings were observed in a glutamatergic model of psychosis, but the role of serotonergic 5-HT2A receptors in information processing is less clear.

Objectives: We studied ERPs in a serotonergic model of psychosis, induced by psilocybin, a psychedelic with 5-HT2A/C agonistic properties, in healthy volunteers.

Methods: Twenty subjects (10M/10F) were given 0.26 mg/kg of psilocybin orally in a placebo-controlled, double-blind, cross-over design. ERPs (P300, MMN) were registered during the peak of intoxication. Correlations between measured electrophysiological variables and psilocin serum levels and neuropsychological effects were also analyzed.

Results: Psilocybin induced robust psychedelic effects and psychotic-like symptoms, decreased P300 amplitude (p = 0.009) but did not affect the MMN. Psilocybin's disruptive effect on P300 correlated with the intensity of the psychedelic state, which was dependent on the psilocin serum levels. We also observed a decrease in N100 amplitude (p = 0.039) in the P300 paradigm and a negative correlation between P300 and MMN amplitude (p = 0.014).

Conclusions: Even though pre-attentive cognition (MMN) was not affected, processing at the early perceptual level (N100) and in higher-order cognition (P300) was significantly disrupted by psilocybin. Our results have implications for the role of 5-HT2A receptors in altered information processing in psychosis and schizophrenia.

Keywords: ERP; Human; MMN; Model of psychosis; P300; Psilocybin.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acoustic Stimulation / methods
  • Adult
  • Aged
  • Attention / drug effects*
  • Attention / physiology
  • Cognition / drug effects*
  • Cognition / physiology
  • Cross-Over Studies
  • Double-Blind Method
  • Electroencephalography / drug effects
  • Electroencephalography / methods
  • Event-Related Potentials, P300 / drug effects*
  • Event-Related Potentials, P300 / physiology
  • Female
  • Hallucinogens / pharmacology*
  • Healthy Volunteers
  • Humans
  • Male
  • Middle Aged
  • Psilocybin / adverse effects
  • Psilocybin / pharmacology*

Substances

  • Hallucinogens
  • Psilocybin